Phase I study on the safety and preliminary efficacy of allogeneic mesenchymal stem cells in hypoxic-ischemic encephalopathy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I study on the safety and preliminary efficacy of allogeneic mesenchymal stem cells in hypoxic-ischemic encephalopathy

Published:2021-03-20 Issue:2 Volume:11 Page:17-29
ISSN:2220-315X
Container-title:World Journal of Experimental Medicine
language:
Short-container-title:WJEM

Author:

Kabataş Serdar,Civelek Erdinç,Kaplan Necati,Savrunlu Eyüp Can,Sezen Gülseli Berivan,Chasan Mourat,Can Halil,Genç Ali,Akyuva Yener,Boyalı Osman,Diren Furkan,Karaoz Erdal

Publisher

Baishideng Publishing Group Inc.

Reference25 articles.

1. Neural stem cell therapies and hypoxic-ischemic brain injury

2. Neurocognitive outcomes in adults following cerebral hypoxia: A systematic literature review

3. Hypoxic‐ischemic‐related cerebrovascular changes and potential therapeutic strategies in the neonatal brain

4. Efficacy of different treatment times of mild cerebral hypothermia on oxidative factors and neuroprotective effects in neonatal patients with moderate/severe hypoxic–ischemic encephalopathy

5. Stem cell therapy for preventing neonatal diseases in the 21st century: Current understanding and challenges

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of cell therapy modalities and outcomes in cerebral palsy;Molecular and Cellular Biochemistry;2024-07-21

2. Clinical cell therapy guidelines for neurorestoration (IANR/CANR 2022);Journal of Neurorestoratology;2022-09

3. The 2021 yearbook of Neurorestoratology;Journal of Neurorestoratology;2022-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP